Akari Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Dec 23 | BuyUS$1,000,001 | Raymond Prudo-Chlebosz | Individual | 473,934 | US$2.11 | |
06 Oct 23 | BuyUS$430,000 | Raymond Prudo-Chlebosz | Individual | 130,303 | US$3.30 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 419,738 | 5.3% |
Institutions | 1,049,265 | 13.2% |
Individual Insiders | 2,609,691 | 32.9% |
General Public | 3,845,001 | 48.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 56.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,307,202 | US$2.2m | 394% | no data | |||
1,165,790 | US$2.0m | 68.5% | no data | |||
847,556 | US$1.4m | 0% | 0.01% | |||
400,383 | US$676.6k | 0% | no data | |||
87,628 | US$148.1k | 0% | 0.07% | |||
76,698 | US$129.6k | -1.15% | no data | |||
48,491 | US$81.9k | -70.4% | 0.34% | |||
23,643 | US$40.0k | 0% | no data | |||
19,355 | US$32.7k | 0% | no data | |||
19,354 | US$32.7k | 0% | 100.0% | |||
14,769 | US$25.0k | 43.8% | no data | |||
10,000 | US$16.9k | -5.53% | no data | |||
10,000 | US$16.9k | 0% | no data | |||
10,000 | US$16.9k | 0% | no data | |||
10,000 | US$16.9k | 0% | no data | |||
10,000 | US$16.9k | 0% | no data | |||
10,000 | US$16.9k | 0% | no data | |||
6,114 | US$10.3k | 0% | no data | |||
1,499 | US$2.5k | -2.73% | no data | |||
150 | US$253.1 | 0% | no data | |||
50 | US$84.4 | 0% | no data | |||
6 | US$10.7 | -25% | no data | |||
5 | US$8.0 | 0% | no data | |||
1 | US$1.3 | 0% | no data |